Cardiol Therapeutics Inc - Ordinary Shares - Class A
CRDL
Get informed when a big investor buys or sells
+ FollowMarket Cap$163.69M
Close$
$0.18
88.4% downside
Current Fair Value
88.4% downsideOvervalued by 88.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $163.69 Million |
|---|---|
| Enterprise Value | $136.06 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.39 |
| Beta | 0.51 |
| Outstanding Shares | 108,987,584 |
Return
| Return on Equity | -149.91% |
|---|---|
| Return on Assets | -115.53% |
| Return on Invested Capital | -145.44% |
Valuation & Multiples
| P/E Ratio | -5.09 |
|---|---|
| PEG | -16.48 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.84 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.81%▼ 24.77% |
|---|---|
| Total Invested | $935,382▼ 97.51% |
| Investors Holding | 20▼ 29.00% |
ESG Score
No data